Calamos Advisors’s CERo Therapeutics Warrants CEROW Stock Holding History

Calamos Advisors’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,500	Closed	-$166	–	1008
2025 Q3	$166	Hold	12,500	–	–	﹤0.01%	919
2025 Q2	$263	Hold	12,500	–	–	﹤0.01%	916
2025 Q1	$166	Hold	12,500	–	–	﹤0.01%	904
2024 Q4	$104	Hold	12,500	–	–	﹤0.01%	902
2024 Q3	$64	Hold	12,500	–	–	﹤0.01%	931
2024 Q2	$250	Hold	12,500	–	–	﹤0.01%	945
2024 Q1	$1.11K	Hold	12,500	–	–	﹤0.01%	942
2023 Q4	$344	Hold	12,500	–	–	﹤0.01%	923
2023 Q3	$895	Hold	12,500	–	–	﹤0.01%	935
2023 Q2	$819	Hold	12,500	–	–	﹤0.01%	995
2023 Q1	$625	Hold	12,500	–	–	﹤0.01%	1131
2022 Q4	$491	Hold	12,500	–	–	﹤0.01%	1220
2022 Q3	$2K	Buy	+12,500	New	+$1.05K	﹤0.01%	1238

Other funds holding CEROW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Calamos Advisors's CEROW Position: Q4 2025 in Review

Calamos Advisors sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 12,500 shares — an estimated $166 sold.

Calamos Advisors first reported a position in CEROW in Q3 2022 and held it in 13 quarters. The position peaked at $2K in Q3 2022. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

Calamos Advisors reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
Calamos Advisors sold 12,500 CERo Therapeutics Warrants shares in Q4 2025, an estimated $166.
Calamos Advisors first reported a position in CERo Therapeutics Warrants in Q3 2022 and held it in 13 quarters.
Calamos Advisors's CERo Therapeutics Warrants position peaked at $2K in Q3 2022.
1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Calamos Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.